Log In
Print
BCIQ
Print
Print this Print this
 

vonoprazan fumarate (TAK-438)

  Manage Alerts
Collapse Summary General Information
Company Takeda Pharmaceutical Co. Ltd.
DescriptionSmall molecule potassium competitive acid blocker
Molecular Target H+/K ATPase pump
Mechanism of Action 
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today